Celltrion is a leading global biopharmaceutical company dedicated to improving the health and well-being of patients.
We have presented a new paradigm to the global biologics market with the launch of the world’s first monoclonal antibody biosimilar.
Celltrion will continue to pursue its goal in promoting the health and well-being of patients.
From key date reminders, abstract closures, program release updates, and speaker announcements, the best place to stay across APLAR Congress information is with the official congress mailing list.
You can opt out at anytime.
If you are translating this website, phrase based translation is used and may not be completely accurate.
